Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

The University of Maryland, Baltimore's Office of Research and Development announced that Encore Path, Inc. of Baltimore signed an exclusive worldwide license agreement for a device technology invented jointly by researchers at the University of Maryland, Baltimore and the University of Maryland Baltimore County that helps stroke patients retrain their bodies to walk.

5 Jun 2010

VA partners with National Institutes of Health to research on Parkinson's disease

Veterans and others with Parkinson's disease who undergo deep brain stimulation may benefit from research co-sponsored by the Department of Veterans Affairs and published recently in the prestigious New England Journal of Medicine.

5 Jun 2010

Researchers induce memory of safety in brain of rats

Researchers have found a way to pharmacologically induce a memory of safety in the brain of rats, mimicking the effect of training. The finding suggests possibilities for new treatments for individuals suffering from anxiety disorders.

4 Jun 2010

HRT patches containing low doses of oestrogen carry less risk of stroke than oral therapy: Study

Hormone replacement therapy skin patches containing low doses of oestrogen carry less risk of stroke than oral therapy and may represent a safer alternative to tablets, suggests a study published on bmj.com today.

4 Jun 2010

Advanced CT scanner allows rapid organ imaging, reduces radiation exposure

UT Southwestern Medical Center is the first site in North Texas to launch the next generation in CT scanners, which allow doctors to image an entire organ in less than a second or track blood flow through the brain or to a tumor - all with less radiation exposure to patients.

3 Jun 2010

Medtronic DBS Therapy improves motor function in patients with advanced Parkinson's disease: Study

In the largest, randomized, controlled study of deep brain stimulation for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor function for up to two years in patients with advanced Parkinson's disease, showing equally strong efficacy for the two most common surgical targets used for the therapy.

3 Jun 2010

Top physicians offer health advice to help people survive during summer

This summer a variety of top physicians at NewYork-Presbyterian Hospital are offering health advice to help survive the travails that come with one of the most active seasons of the year.

3 Jun 2010

DBS procedure effective for treating Parkinson's disease

Studies have shown that a "brain pacemaker" called deep brain stimulation (DBS) is an effective treatment for Parkinson's disease.

3 Jun 2010

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

An enzyme implicated in osteoporosis, arthritis, atherosclerosis and cancer metastasis -- cathepsin K -- eluded reliable detection in laboratory experiments in the past. Now, a research team at the Georgia Institute of Technology has developed an assay that reliably detects and quantifies mature cathepsin K using a technique called gelatin zymography.

2 Jun 2010

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

Q Therapeutics, Inc. announced today that Piotr Walczak, M.D., of Johns Hopkins University has received notification of a $1,000,000 grant to be awarded by the Maryland Stem Cell Research Fund (MSCRF) which will enable further study of Q's human neural glial cell product Q-Cells® in preclinical models of demyelinating disease.

2 Jun 2010

Concentric Medical receives expanded indication for DAC family of neurovascular catheters

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced an important expanded indication for the full line of DAC™ Neurovascular Catheters. CE Mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature.

2 Jun 2010

Synthetic peptide repairs, regenerates stroke-injured brain tissue

A synthetic version of a naturally occurring peptide promoted the creation of new blood vessels and repaired damaged nerve cells in lab animals, according to researchers at Henry Ford Hospital in Detroit.

2 Jun 2010

Motion Therapeutics to launch BalanceWear Stabilizing Garments for MS

For those who suffer from balance disorders and loss of mobility, promising results from a new stabilizing device may help to reestablish mobility, confidence and independence. This week, Motion Therapeutics premieres its BalanceWear™ Stabilizing Garments at the 24th Annual Meeting for the Consortium of Multiple Sclerosis Centers in San Antonio.

2 Jun 2010

Texas Heart Institute at St. Luke's Episcopal Hospital performs 1000th carotid artery stent procedure

The Texas Heart Institute (THI) at St. Luke's Episcopal Hospital has announced another major milestone in improved patient care, after performing its 1000th carotid artery stent procedure. Carotid artery stenting (CAS) has emerged as a less invasive treatment for stroke-causing blockages in the carotid artery, meaning patients generally have fewer risks for complications, shorter hospital stays and recovery times and less expense.

2 Jun 2010

Mannitol improves effectiveness of HUCBs in neonatal rat models of cerebral palsy

The sugar-alcohol compound mannitol improved the therapeutic effectiveness of human umbilical cord blood cells injected into neonatal rat models of cerebral palsy, reports a new international study led by the University of South Florida. The mannitol opened the blood-brain barrier by temporarily shrinking the tight endothelial cells that make up the barrier.

2 Jun 2010

Juvenile Diabetes Research Foundation International honors Roche with "Chancellor's Award"

Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.

From Roche Sequencing and Life Science 2 Jun 2010

Platelets play important role in cerebral malaria: Research

Scientists are making strides against cerebral malaria, a fatal form of malaria in children that can ravage the brain and is extremely difficult to treat. New research points to platelets - known for their role in blood clotting - as playing an important role in the disease, stimulating the immune system and turning on molecules that increase inflammation. The inflammation leads to the obstruction of blood vessels in the brain, causing brain damage similar to that seen with a stroke.

2 Jun 2010

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.

2 Jun 2010

Women unaware of their heart disease risk: Report

The Australian Institute of Health and Welfare has come up with results of their study funded by the National Heart Foundation that warns Australian women of their heart disease risk. It says that heart disease is the leading killer of Australian women and most women (eight out of ten) think that heart disease kills only “old men”.

31 May 2010

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

On the verge of a BC Government announcement on a new policy on generic medication pricing and a Long Term Pharmacy Agreement, the Better Pharmacare Coalition (BPC) is mobilizing its two million members to ensure Government keeps its promise that patient interests and input are reflected in the new BC PharmaCare drug review process.

31 May 2010

Stroke News and Research

Further Reading

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

VA partners with National Institutes of Health to research on Parkinson's disease

Researchers induce memory of safety in brain of rats

HRT patches containing low doses of oestrogen carry less risk of stroke than oral therapy: Study

Advanced CT scanner allows rapid organ imaging, reduces radiation exposure

Medtronic DBS Therapy improves motor function in patients with advanced Parkinson's disease: Study

Top physicians offer health advice to help people survive during summer

DBS procedure effective for treating Parkinson's disease

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

Concentric Medical receives expanded indication for DAC family of neurovascular catheters

Synthetic peptide repairs, regenerates stroke-injured brain tissue

Motion Therapeutics to launch BalanceWear Stabilizing Garments for MS

Texas Heart Institute at St. Luke's Episcopal Hospital performs 1000th carotid artery stent procedure

Mannitol improves effectiveness of HUCBs in neonatal rat models of cerebral palsy

Juvenile Diabetes Research Foundation International honors Roche with "Chancellor's Award"

Platelets play important role in cerebral malaria: Research

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

Women unaware of their heart disease risk: Report

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News